| Net Cash Provided by (Used in) Operating Activities |
-4.89K |
USD |
-125% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
80M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
5.2M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-4.89K |
USD |
-125% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
84.9K |
USD |
+10.1% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
84.9K |
USD |
+10.1% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
20M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
1.23M |
USD |
0% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Interest Expense |
6.74K |
USD |
+57.4% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |